64416-07-5

Upstream product

• 4009-98-7 (methoxymethyl)triphenylphosphonium chloride 
• 4255-62-3 4,4-dimethylcyclohexane-1-one 
• 4009-98-7 (methoxymethyl)triphenylphosphonium chloride 
• 1073-13-8 4,4-dimethylcyclohexenone 
• 33670-32-5 methoxymethyltriphenylphosphonium bromide 

Downstream Products

• 394734-96-4 4,4-dimethylcyclohexanecarbaldehyde 
• 1007578-77-9 [(4,4-dimethylcyclohexyl)methyl]amine hydrochloride 
• 1007578-76-8 [(4,4-dimethylcyclohexyl)methyl](phenylmethyl)amine 
• 1210879-13-2 C₁₁H₂₂O 
• 140423-42-3 1,4,4-trimethylcyclohexanecarbaldehyde 

Relevant academic research and scientific papers

OXYSTEROLS AND METHODS OF USE THEREOF

Compounds are provided according to Formula (A): and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R1, R2, R3, R4, R5, R6, and RG are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

As opioid receptor antagonists or inverse agonists of the novel compounds

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.

PYRAZOLE AMIDE DERIVATIVE

The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.

COMPOSITIONS AND METHODS FOR MODULATING FXR

The present invention relates to compounds of Formula (I), a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; wherein variables are as defined herein; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesiod X receptors (FXR).

NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.